
If you're aged over 18 and living with #diabetes, you could take part in a study run by researchers at @UniofNewcastle, who're looking at how heat waves impact your day-to-day diabetes management 🌡️💦 #TrialTuesday

Research Associate @ Newcastle University

If you're aged over 18 and living with #diabetes, you could take part in a study run by researchers at @UniofNewcastle, who're looking at how heat waves impact your day-to-day diabetes management 🌡️💦 #TrialTuesday

Metabolomics identifies a unique aerobic exercise metabolic phenotype in type 1 #diabetes with diagnostic potential for maximal aerobic capacity. Research by @Roberts_Lab, @guystu, @HNERC_NclUni, @nucDIABETES @LeedsMedHealth #T1D #Metabolomics tinyurl.com/2vy46erp 🔓

🌍 Here at the DRMG, we are celebrating World Diabetes Day by wearing blue! From bench to bedside, our incredible team of lab technicians, researchers, and clinicians are committed to improving the lives of those living with diabetes #WorldDiabetesDay @IntDiabetesFed

First in-person conference in a long time, really enjoyed being and presenting @DRWFDiabetes funded work at #ADA2023 @HNERC_NclUni @DRMG_NCL

Pre-Meal Whey Protein Alters Postprandial Insulinemia by Enhancing β-Cell Function and Reducing Insulin Clearance in T2D. Our latest Dan West, @EmmaJStevenson, @guystu @kbowdendavies, Mark Walker @NIHR_Newc_CRF @NuTHResearch @NCLUni_SportSci @HNERC_NclUni academic.oup.com/jcem/advanc…

New paper examining the effects of collagen peptide supplementation on exercise induced GI symptoms Open access link: link.springer.com/article/10…

It's World Diabetes day 🩸 Broaden your understanding of this metabolic syndrome by reading some publications from our members of HNERC @guystu @kwrsmith @EmmaJStevenson Dr Daniel West drc.bmj.com/content/10/3/e00…

Consuming a low-dose of pre-meal whey protein increases the daily time spent in euglycaemia in adults with T2D / w @guystu @kbowdendavies @EmmaJStevenson Mark Walker Dan West @NIHR_Newc_CRF @NCLUni_SportSci @NclBNS @ArlaIngredients drc.bmj.com/content/10/3/e00…

So what are the implications of the study? Individuals with no β-cell function may need more support to manage nocturnal and post meal periods whereas those with C-peptide positivity could potentially pursue more ambitious glucose targets (9/9)

Dig into supplementary table 1. to see mixed-effect analysis of individual nocturnal and meal time events, exploring diabetes duration, BMI, basal insulin, use of a continuous or flash glucose monitor and (for postprandial) meal type, carbohydrate and bolus insulin intake (8/9)

Are the less marked improvements at meal times due to paradoxical glucagon rises seen in T1D, which seem unaffected by β-cell function? pubmed.ncbi.nlm.nih.gov/3061… + jci.org/articles/view/134057 (7/9)

Improvements in post meal glucose with increasing β-cell function were less marked than overnight. Sig increase in time in normoglycemia 0-300min but not 0-120min. Individual events analysis did find those with high C-pep were sig less likely to have a post meal hypo event (6/9)

So what did we find overnight: ⬆️β- cell function was associated with more time spent in normoglyceamia, ⬇️hyperglycaemia and glycaemic variability. When individual events were analysed, low C-peptide had reducing hyperglycaemia compared with undetectable β-cell function (5/9)

But where does that improvement occur during the day? Andy Shaw (doctor on a AFP project) did an amazing job digging through food diaries and CGM data with me, exploring overnight and meal time periods which are common periods of disrupted glucose (4/9)

These paper show⬆️beta-cell function seems to ⬆️time in normoglycaemia, ⬇️time spent in hyperglycaemia,⬇️ glycaemic variability, and potentially ⬇️ time spent + incidence of hypoglycaemia (3/9)

We know that greater beta-cell function improves CGM parameters in newly diagnosed T1D (https://t.co/sCu0cVLGXt), islet transplant patients (https://t.co/1TPGkMM0rR), and recently shown in those with longer duration T1D (https://t.co/pXOPoskuwG + https://t.co/aKeEqO5xv8) (2/9)